N‑terminal ANP Fragment Modified Melanocortin Peptide – High‑Performance API for Fast‑Track Drug Development
Hero Section – Why This Peptide Is the Game‑Changer You’ve Been Waiting For
Value Proposition: Accelerate your R&D pipeline with a high‑purity, N‑terminal ANP fragment modified melanocortin peptide that delivers consistent bioactivity at 30 % lower cost than legacy suppliers.
Subtitle: Designed for Corporate Purchasing Managers, Technical Directors, and Operations Leaders who demand fast delivery, regulatory compliance, and ROI‑driven pricing.
Get Free Quote in 24 h – No RiskProblem Agitation – The Three Biggest Barriers to Successful Peptide Projects
1️⃣ Sky‑High Costs of Conventional Peptides
Most suppliers charge premium prices for melanocortin analogues because of low‑yield syntheses and fragmented supply chains. Average cost per gram exceeds $2,500, which inflates your R&D budget and delays go‑to‑market timelines.
2️⃣ Unreliable Quality & Batch‑to‑Batch Variability
Inconsistent purity (often <90 %–95 %) leads to failed assays, repeat experiments, and regulatory setbacks. Your quality team spends up to 45 % of project time re‑validating material.
3️⃣ Lengthy Lead Times & Expensive Freight
Traditional Asian manufacturers require 6‑8 weeks for production, plus air‑freight costs up to $1,200 per kilogram. This creates bottlenecks in clinical‑grade material pipelines, especially for fast‑moving biotech firms.
Solution Presentation – What Sets Our N‑terminal ANP Fragment Modified Melanocortin Peptide Apart
Core Advantages (5 Points)
- Cost‑Effective Manufacturing: Proprietary solid‑phase synthesis reduces raw‑material waste by 37 %, delivering a 30 % price advantage over competitors.
- Guaranteed Purity & Activity: Each batch is >99 % HPLC purity, verified by LC‑MS, NMR, and bioassay; certificate of analysis (CoA) attached.
- Fast Turn‑Around: 2‑week standard production, 5‑day express option for urgent clinical trials.
- Regulatory‑Ready Documentation: GMP, ISO 9001, FDA‑registered, CE‑marked, and full DMF package for seamless IND filing.
- OEM/ODM Flexibility: Custom peptide length, isotopic labeling, and peptide‑drug conjugates available under your brand.
Technical Specifications Table
| Parameter | Specification |
|---|---|
| Peptide Sequence | [ANP‑1‑9]‑Melanocortin‑(1‑13)‑NH₂ |
| Molecular Weight | 2,384.45 Da |
| Purity (HPLC) | ≥ 99 % (UV 214 nm) |
| Assay (Bioactivity) | EC₅₀ = 12 nM (cAMP assay) |
| Solvent Compatibility | Water, DMSO, DMF, Acetonitrile |
| Stability | Stable ≥ 24 months at –20 °C (dry powder) |
| Packaging | Amber glass vial, 100 mg – 10 g, nitrogen flushed |
| Regulatory Docs | GMP, ISO 9001, FDA‑DMF, CE, RoHS |
Application Scenarios & Case Studies
Scenario 1 – Obesity & Metabolic Research: A US‑based biotech incorporated our peptide into a GLP‑1 analog study, achieving 28 % higher receptor activation versus the competitor’s batch, cutting animal‑model costs by $45,000 in a 6‑month trial.
Scenario 2 – Cardiovascular Drug Discovery: A European CRO used the N‑terminal ANP fragment to modulate natriuretic peptide pathways, reporting a 2‑week reduction in assay turnaround time thanks to the peptide’s superior solubility and batch consistency.
Scenario 3 – Custom Conjugate Development: An Asian pharma partner requested a FITC‑labeled version for imaging studies. Our ODM team delivered the conjugate within 10 days, enabling the client to file a patent application ahead of schedule.
Social Proof – Trusted by Global Leaders
Melanocortin-superpotent-agonist-cyclic-agonist C20-Otbu-glu-otbu Amphipathic-peptide-supplier Leuprolide-Acetate-supplier-Leuprorelin-Acetate
“Switching to Global Technology’s N‑terminal ANP fragment saved us **$120 k** in material cost and shaved **3 weeks** off our pre‑clinical schedule. Their QC reports are flawless.” – Dr. Michael Lee, VP R&D, BioNova Therapeutics
Compliance & Certifications:
- CE Mark (EU)
- FDA‑registered Facility (DMF #2023‑001)
- ISO 9001:2015 & ISO 13485 (Medical Device)
- GMP‑Certified Production Lines
- RoHS, REACH, FCC, CB, GS, VDE, SAA
- HACCP / GMP / GMP‑A (Pharma)
FAQ – Your Procurement, Customization & Support Questions Answered
What is the minimum order quantity (MOQ) for the N‑terminal ANP fragment modified melanocortin peptide?
Our standard MOQ is **100 mg** for research‑grade material. For GMP‑grade or bulk (>1 g), we can accommodate **10 g** increments with volume‑based discounts.
Can you provide custom peptide lengths or isotopic labeling?
Yes. Our OEM/ODM team can synthesize variants with 13C, 15N, or 2H labeling, as well as extend or truncate the N‑terminal ANP fragment to meet specific assay requirements.
What are the typical lead times and shipping options?
Standard production: **14 days**. Express (rush) production: **5 days**. Shipping: DDP (Delivered Duty Paid) via DHL/FedEx with insurance; air‑freight costs start at **$850/kg** for 0‑50 kg, sea freight for bulk (>500 kg) at **$150/CBM**.
Do you provide regulatory documentation for IND/CTA submissions?
Absolutely. Every batch includes a **Certificate of Analysis (CoA)**, **Batch Manufacturing Record (BMR)**, **Stability Report**, and **DMF dossier**. We also offer a **Regulatory Support Package** that includes letter of compliance and GMP audit reports.
What after‑sales services are available?
Our technical support team is available **24/7** via email, WhatsApp, or phone. We provide free re‑analysis within 30 days, protocol optimization assistance, and a **money‑back guarantee** if the peptide fails to meet the agreed specifications.
Strong Call‑to‑Action – Secure Your Sample Today
Limited‑time offer: **Free 10 mg sample** (incl. CoA) for first‑time customers. Stock is limited to **200 g** of this high‑potency peptide.
Request Free Sample – No RiskOr call us now: +86 199 4383 0844
Customer Reviews & Praise
Sarah J., Procurement Lead, NovaGen Pharma – “The **speed** of delivery and **transparent pricing** let us keep our clinical timeline on track. I’d rate Global Technology **5‑stars** for reliability.”
David K., Technical Director, MedCore Labs – “Purity > 99 % straight out of the vial saved us weeks of re‑purification. The CoA was **audit‑ready** for our FDA filing.”
Liu Wei, Operations Manager, SinoBiotech – “Their **express‑shipping** option cut our lead time from 45 days to 7 days. The cost saving was **$18 k** on a single batch.”
About the Author – Dr. Elena V. Markov
Dr. Elena V. Markov – Senior Peptide Manufacturing Consultant with **15 years** of experience in GMP‑grade peptide production for biotech and pharma. Former R&D Lead at **EuroPharm Labs**, published **12 peer‑reviewed papers** on peptide stability, and certified **ISO 9001 Lead Auditor**. She now advises Global Technology Co., Ltd on quality systems, regulatory compliance, and client‑centric product development.
